Bioinformatics Analysis Identifies EPAS1 as a Novel Prognostic Marker Correlated with Immune Infiltration in Acute Myeloid Leukemia

Figure 7

(a–e) Association of EPAS1 expression and clinicopathologic variables including (a) WBC count, (b) PB blasts, (c) BM blasts, (d) FLT3 mutation, and (e) NPM1 mutation. PB: peripheral blood; BM: bone marrow.

(a)

(b)

(c)

(d)

(e)